 Acadian Asset Management LLC bought a new position in NeuBase Therapeutics NASDAQ:NBSE during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission SEC. The firm bought 7,589 shares of the companys stock, valued at approximately 54,000. A number of other hedge funds and other institutional investors also recently modified ... 